Xintela AB (publ) announced the appointment of Caroline Ehrencrona to a role responsible for the company's Clinical Development and Regulatory Affairs operations. Caroline Ehrencrona takes up the post on June 1, 2016 and will strengthen Xintela's operations for upcoming clinical studies and will be responsible for the day-to-day contact with regulatory authorities. Caroline Ehrencrona has more than ten years experience in the biotech industry and has most recently held a post as Project Director & QA Manager at TikoMed AB.